Log In
Print
BCIQ
Print
Print this Print this
 

IBI-10090

  Manage Alerts
Collapse Summary General Information
Company Icon Bioscience Inc.
DescriptionUndisclosed anti-inflammatory agent delivered using Verisome technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationCataract
Indication DetailsReduce inflammation after cataract surgery
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today